Dorzolamide Hydrochloride Ophthalmic Solution Solution/ Drops
Product Images NDC 42571-141

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride Ophthalmic Solution (NDC 42571-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dorzolamide Crtn

The packaging label for Dorzolamide HCL Ophthalmic Solution, USP 2% (Dorzolamide Equivalent 22.3 mg/mL) by Micro Labs Limited. The label shows it is a 10 mL solution for topical application in the eye, Rx only. It includes storage instructions (15° to 30°C), preservative information (Benzalkonium chloride 0.0075%), and manufacturer details in India and the USA. The package contains multiple panels with regulatory details, barcodes, and directions indicating it is sterile and must be kept out of reach of children.*

FDA Label Image

Dorzolamide Lbl

Label for Dorzolamide Hydrochloride Ophthalmic Solution USP 2%, a 10 mL eye drop solution. The label shows storage instructions (15° to 30°C, protect from light), manufacturer Micro Labs USA Inc., and indicates it is made in India. It includes the NDC 42571-141-26 with a barcode and batch detail area.*

FDA Label Image

Fig A (Dorzolamidefiga)

Illustration showing a bottle of Dorzolamide Hydrochloride Ophthalmic Solution with labeled components including the cap, tear off tamper evident ring, and the bottle itself, indicating parts to remove before use.*

FDA Label Image

Fig B (Dorzolamidefigb)

An instructional illustration labeled Fig. B shows hands applying a tamper-evident safety ring to the neck of an ophthalmic solution bottle, demonstrating proper placement of the ring before opening.*

FDA Label Image

Fig C (Dorzolamidefigc)

An instructional illustration labeled Fig. C showing hands holding a bottle with a dropper cap, demonstrating a twisting motion to open or close the cap. The image is likely part of usage instructions for Dorzolamide Hydrochloride Ophthalmic Solution 20 mg/mL.*

FDA Label Image

Fig D (Dorzolamidefigd)

Illustration showing a person administering ophthalmic drops to the eye by gently pulling down the lower eyelid and instilling a drop into the conjunctival sac using the dropper tip near the eye.*

FDA Label Image

Fig E (Dorzolamidefige)

An instructional illustration labeled Fig. E shows a person administering ophthalmic solution drops into the eye. One hand holds the eye open while the other hand tilts a dropper bottle above the eye to release the drops.*

FDA Label Image

Fig F (Dorzolamidefiguref)

An instructional illustration showing hands holding an ophthalmic solution bottle. The image depicts rotating the bottle cap, likely indicating how to open the cap or prepare the eye drops for use. The diagram is labeled 'Fig. F'.*

FDA Label Image

Structure (Dorzolamidestructure)

Chemical structure diagram of Dorzolamide Hydrochloride, showing its molecular arrangement including sulphur, nitrogen, oxygen atoms, and chloride (HCl) group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.